{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:59:42Z","timestamp":1776286782748,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["BM1406"],"award-info":[{"award-number":["BM1406"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.coph.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T20:42:44Z","timestamp":1554410564000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Role of the purinergic P2X receptors in osteoclast pathophysiology"],"prefix":"10.1016","volume":"47","author":[{"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2019.02.013_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.coph.2019.02.013_bib0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1359\/jbmr.081210","article-title":"Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue","volume":"24","author":"Cardoso","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.coph.2019.02.013_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00418-018-1639-z","article-title":"Pathologic conditions of hard tissue: role of osteoclasts in osteolytic lesion","volume":"149","author":"Kitazawa","year":"2018","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.coph.2019.02.013_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2019.02.013_bib0025","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/0929867321666141215094749","article-title":"The role of P2X receptors in bone biology","volume":"22","author":"Jorgensen","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.coph.2019.02.013_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2018.03.016","article-title":"The purinergic P2X7 ion channel receptor-a \u2018repair\u2019 receptor in bone","volume":"52","author":"Jorgensen","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coph.2019.02.013_bib0035","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JME-14-0226","article-title":"P2X7 receptors: role in bone cell formation and function","volume":"54","author":"Agrawal","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.coph.2019.02.013_bib0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1469-7793.1998.495bh.x","article-title":"ATP is a potent stimulator of the activation and formation of rodent osteoclasts","volume":"511","author":"Morrison","year":"1998","journal-title":"J Physiol (Lond)"},{"key":"10.1016\/j.coph.2019.02.013_bib0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bone.2018.02.006","article-title":"Antagonists to TRPV1, ASICs and P2X have a potential role to prevent the triggering of regional bone metabolic disorder and pain-like behavior in tail-suspended mice","volume":"110","author":"Hanaka","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.coph.2019.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.bjp.0705574","article-title":"Effects of A-317491, a novel and selective P2X3\/P2X2\/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration","volume":"140","author":"McGaraughty","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2019.02.013_bib0055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/35039519","article-title":"Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice","volume":"407","author":"Cockayne","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.coph.2019.02.013_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2012.05.008","article-title":"Chronic administration of the selective P2X3, P2X2\/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice","volume":"688","author":"Hansen","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2019.02.013_bib0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bjp.0706628","article-title":"A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates","volume":"147","author":"Monkkonen","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2019.02.013_bib0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00774-017-0814-y","article-title":"Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2\/3 receptors","volume":"36","author":"Tanaka","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.coph.2019.02.013_bib0075","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/0929867321666141215094749","article-title":"The role of P2X receptors in bone biology","volume":"22","author":"Jorgensen","year":"2015","journal-title":"Curr. Med. Chem"},{"key":"10.1016\/j.coph.2019.02.013_bib0080","doi-asserted-by":"crossref","first-page":"S418","DOI":"10.1359\/JBMR.040108","article-title":"P2X7 nucleotide receptors act through two distinct mechanisms to regulate osteoclast survival","volume":"19","author":"Korcok","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.coph.2019.02.013_bib0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/FPC.0b013e3280951625","article-title":"Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment","volume":"17","author":"Ohlendorff","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.coph.2019.02.013_bib0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bone.2018.01.007","article-title":"SNPs in the vicinity of P2X7R, RANK\/RANKL\/OPG and Wnt signalling pathways and their association with bone phenotypes in academy footballers","volume":"108","author":"Varley","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.coph.2019.02.013_bib0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fendo.2016.00141","article-title":"A candidate gene association study of bone mineral density in an Iranian population","volume":"7","author":"Dastgheib","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.coph.2019.02.013_bib0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00774-017-0862-3","article-title":"Genetic interaction of purinergic P2X7 receptor and ER-alpha polymorphisms in susceptibility to osteoporosis in Chinese postmenopausal women","volume":"36","author":"Wang","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.coph.2019.02.013_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/odi.12564","article-title":"Genetic determinants and postorthodontic external apical root resorption in Czech children","volume":"23","author":"Borilova Linhartova","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.coph.2019.02.013_sbref0110","article-title":"P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2019.02.013_bib0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11302-016-9495-6","article-title":"Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury","volume":"12","author":"Varley","year":"2016","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.coph.2019.02.013_bib0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00198-012-2035-5","article-title":"Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis","volume":"24","author":"Husted","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.coph.2019.02.013_bib0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ejhg.2011.245","article-title":"Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women","volume":"20","author":"Gartland","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.coph.2019.02.013_bib0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ejhg.2011.253","article-title":"Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures","volume":"20","author":"Jorgensen","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.coph.2019.02.013_sbref0135","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/jbmr.2740","article-title":"Pannexin-1 and P2X7-receptor are required for apoptotic osteocytes in fatigued bone to trigger RANKL production in neighboring bystander osteocytes","volume":"31","author":"Cheung","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.coph.2019.02.013_sbref0140","article-title":"The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2019.02.013_bib0145","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5483\/BMBRep.2018.51.9.126","article-title":"The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis","volume":"51","author":"Kim","year":"2018","journal-title":"BMB Rep"},{"key":"10.1016\/j.coph.2019.02.013_bib0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.archoralbio.2017.05.002","article-title":"Extracellular ATP is a key modulator of alveolar bone loss in periodontitis","volume":"81","author":"Binderman","year":"2017","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.coph.2019.02.013_bib0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S8756-3282(02)00877-3","article-title":"Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappaB ligand","volume":"31","author":"Buckley","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.coph.2019.02.013_bib0160","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1074\/jbc.M104608200","article-title":"Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors","volume":"277","author":"Jorgensen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2019.02.013_bib0165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00223-002-2098-y","article-title":"Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro","volume":"73","author":"Gartland","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.coph.2019.02.013_bib0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ddr.1180","article-title":"P2 nucleotide receptors in osteoclasts","volume":"53","author":"Naemsch","year":"2001","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.coph.2019.02.013_bib0175","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2741\/208","article-title":"Bone phenotypes of P2 receptor knockout mice","volume":"3","author":"Orriss","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.coph.2019.02.013_bib0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S8756-3282(00)00351-3","article-title":"Expression of P2 receptors in bone and cultured bone cells","volume":"27","author":"Hoebertz","year":"2000","journal-title":"Bone"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218301371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218301371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:49:09Z","timestamp":1761461349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489218301371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"alternative-id":["S1471489218301371"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2019.02.013","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the purinergic P2X receptors in osteoclast pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}